Analyst Ratings for Travere Therapeutics (TVTX)
TVTX Rating Summary
TVTX Price Target Summary
- Highest: $70.00 (Citi)
- Lowest: $31.00 (Scotiabank)
- Average: $54.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$54.07 (-4.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$54.07 (-4.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/14/2026 | Piper Sandler | Allison M. Bratzel | Upgrade | Overweight (Neutral) |
49.00 (38.00) |
30.70 (56.71) |
84.72% | Details |
| 8/25/2025 | Evercore ISI » Updated 10/1/2025 |
Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
35.00 (45.00) |
17.92 (56.71) |
216.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
